CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Rigel Pharmaceuticals Inc  (RIGL)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Rigel Pharmaceuticals Inc's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

RIGL Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change -28.73 % -64.86 % -71.07 % 65.78 % 130.9 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 52 # 828 # 613 # 669 # 663
Seq. Revenue Change 19.47 % -20.21 % -56.25 % 70.89 % -41.09 %
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Rigel Pharmaceuticals Inc has managed to improve its Revenue sequentially to $4 millions by 19.47 % faster than Gross Profit increase of 19.47 % to $4 millions, this led to contraction in Gross Margin to 100 %, a new company low.

Observing first quarter 2017 results within Major Pharmaceutical Preparations industry 6 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 52, from total ranking in previous quarter at 828.
Learn about Gross Margin
RIGL's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 7
Sector # 17
S&P 500 # 52

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Rigel Pharmaceuticals Inc's (Mar 31 2017) Gross Profit $ 4 RIGL's Income Statement
Rigel Pharmaceuticals Inc's (Mar 31 2016) Gross Profit $ 5 Quarterly RIGL's Growth
RIGL's Profits by Division See RIGL's Profits by Segment

Other Gross Margin Profitability Ratios
RIGL's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
RIGL's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for RIGL's Competitors
Gross Margin Profit Margin for Rigel Pharmaceuticals Inc's Suppliers
Gross Margin Profit Margin for RIGL's Customers

You may also want to know
RIGL's Annual Growth Rates RIGL's Profitability Ratios RIGL's Asset Turnover Ratio RIGL's Dividend Growth
RIGL's Roe RIGL's Valuation Ratios RIGL's Financial Strength Ratios RIGL's Gross Profit Growth
RIGL's Roa RIGL's Inventory Turnover Ratio RIGL's Growth Rates RIGL's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Major Pharmaceutical Preparations Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Onconova Therapeutics, Inc.  100.00 %$ 0.210 $ 0.210 
Ophthotech Corp.  100.00 %$ 1.662 $ 1.662 
Progenics Pharmaceuticals Inc  100.00 %$ 2.347 $ 2.347 
Corbus Pharmaceuticals Holdings, Inc.  100.00 %$ 1.294 $ 1.294 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.213 $ 6.213 
Dermira, Inc.  100.00 %$ 1.066 $ 1.066 
Novan, Inc.  100.00 %$ 0.100 $ 0.100 
Northwest Biotherapeutics Inc  100.00 %$ 0.068 $ 0.068 
Pharmathene, Inc  100.00 %$ 0.804 $ 0.804 
Prothena Corp Plc  100.00 %$ 0.259 $ 0.259 
Checkpoint Therapeutics, Inc.  100.00 %$ 0.693 $ 0.693 
Cerulean Pharma Inc.  100.00 %$ 1.192 $ 1.192 
Cempra, Inc.  100.00 %$ 4.872 $ 4.872 
Clearside Biomedical, Inc.  100.00 %$ 0.005 $ 0.005 
Celsion Corp  100.00 %$ 0.125 $ 0.125 
Conatus Pharmaceuticals Inc.  100.00 %$ 6.998 $ 6.998 
Chimerix Inc  100.00 %$ 1.078 $ 1.078 
Paratek Pharmaceuticals, Inc.  100.00 %$ 0.018 $ 0.018 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.133 $ 0.133 
Newlink Genetics Corp  100.00 %$ 2.761 $ 2.761 
Ionis Pharmaceuticals Inc  100.00 %$ 110.304 $ 110.304 
Fibrogen Inc  100.00 %$ 26.891 $ 26.891 
Intra-cellular Therapies, Inc.  100.00 %$ 0.095 $ 0.095 
Abeona Therapeutics Inc.  100.00 %$ 0.186 $ 0.186 
Five Prime Therapeutics Inc  100.00 %$ 10.135 $ 10.135 
Heat Biologics, Inc.  100.00 %$ 0.024 $ 0.024 
Geron Corp  100.00 %$ 0.537 $ 0.537 
Immunogen Inc  100.00 %$ 28.499 $ 28.499 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.185 $ 0.185 
Enanta Pharmaceuticals Inc  100.00 %$ 8.959 $ 8.959 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com